Information Provided By:
Fly News Breaks for May 29, 2018
MCK
May 29, 2018 | 07:35 EDT
Leerink analyst David Larsen lowered his price target for McKesson to $160 from $170 saying he is slightly more cautious on the company and the drug distribution group following its earnings report and call. Continued commentary of stabilizing drug pricing trends bodes well for the group, but the analyst is still worry about renewals, generic pricing pressure, and a slowdown in list price inflation. Larsen reiterates a Market Perform rating on the shares.
News For MCK From the Last 2 Days
MCK
I agree to the thefly.com's disclaimer & terms of use
About Privacy Terms of Use

© 1996-2018 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.